18 β-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting immune cells from ferroptosis

ConclusionThe findings of the present study unraveled a novel mechanism underlying the anti-cancer and immunomodulatory activity of 18 β-GA and support that 18β-GA holds potential to be used as an immune enhancer for lung cancer prevention or treatment.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research